Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sana M Arnouk

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|April 24, 2025
Epo-calypse nowSana M Arnouk, Jo A Van Ginderachter
Cancers|May 17, 2019
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-DeliveryAleksandar Murgaski, Pauline M R Bardet, Sana M Arnouk, et al.
Frontiers in Immunology|August 1, 2020
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer ImmunotherapyEls Lebegge, Sana M Arnouk, Pauline M R Bardet, et al.
Cancers|October 16, 2025
VSIG4 Is Dispensable for Tumor Growth and Metastasis in Murine Colorectal and Breast Cancer ModelsEls Lebegge, Neema Ahishakiye Jumapili, Jolien Van Craenenbroeck, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked NanobodiesEvangelia Bolli, Maximilian Scherger, Sana M Arnouk, et al.
Theranostics|January 3, 2023
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targetingMarco Erreni, Francesca D'Autilia, Roberta Avigni, et al.
Frontiers in Immunology|December 19, 2022
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironmentMáté Kiss, Els Lebegge, Aleksandar Murgaski, et al.
Cancer Research|August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive MacrophagesAleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Cancer Immunology Research|December 28, 2020
IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin DMáté Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|April 24, 2025
Epo-calypse nowSana M Arnouk, Jo A Van Ginderachter
Cancers|May 17, 2019
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-DeliveryAleksandar Murgaski, Pauline M R Bardet, Sana M Arnouk, et al.
Frontiers in Immunology|August 1, 2020
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer ImmunotherapyEls Lebegge, Sana M Arnouk, Pauline M R Bardet, et al.
Cancers|October 16, 2025
VSIG4 Is Dispensable for Tumor Growth and Metastasis in Murine Colorectal and Breast Cancer ModelsEls Lebegge, Neema Ahishakiye Jumapili, Jolien Van Craenenbroeck, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2021
Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked NanobodiesEvangelia Bolli, Maximilian Scherger, Sana M Arnouk, et al.
Theranostics|January 3, 2023
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targetingMarco Erreni, Francesca D'Autilia, Roberta Avigni, et al.
Frontiers in Immunology|December 19, 2022
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironmentMáté Kiss, Els Lebegge, Aleksandar Murgaski, et al.
Cancer Research|August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive MacrophagesAleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Cancer Immunology Research|December 28, 2020
IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin DMáté Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, et al.
Pageof 2